Amjevita can cost over $6,000 per dose without insurance. Learn how to save with copay cards, discount programs, and patient assistance in 2026.
Amjevita (Adalimumab-Atto) is a biologic medication that can cost thousands of dollars per dose without insurance. If you're dealing with sticker shock after seeing the price of your prescription, you're not alone — and you have more options to bring the cost down than you might think.
This guide covers every major way to save money on Amjevita in 2026, from manufacturer copay programs to patient assistance and discount cards.
Let's start with the numbers. Amjevita's pricing depends on which version your pharmacy dispenses:
For most patients taking 40 mg every other week, that translates to roughly $3,100 to $6,600 per month or $40,000 to $85,000 per year without any discounts or insurance coverage.
These are list prices — the actual amount you pay depends on your insurance, copay assistance, and which savings programs you use. The good news is that very few patients actually pay these full amounts.
The single best savings option for most patients is the Amgen SupportPlus Co-Pay Program. Here's how it works:
This is the first program you should check if you have private insurance. The enrollment process is straightforward, and the savings can be substantial — turning a $500+ monthly copay into $0.
If you're uninsured or underinsured and can't afford Amjevita, the Amgen Safety Net Foundation may provide the medication at no cost. Key details:
This is a true patient assistance program (PAP) funded by Amgen. If you meet the eligibility criteria, you receive your medication at absolutely no cost.
Prescription discount cards can reduce the cash price of Amjevita, though savings on biologics are typically more limited than for generic medications. Options to check include:
Discount cards work best for patients who are paying cash (no insurance) and don't qualify for the Amgen Safety Net Foundation. The savings may be modest compared to the list price, but every dollar helps with a medication this expensive.
Here's something many patients don't know: Amjevita is available at two different list price tiers. When Amgen launched the drug in 2023, they created a standard-priced version and a lower-priced version (sometimes called the "low-WAC" option).
The lower-priced version is approximately $1,557 per 40 mg pen compared to $3,288 for the standard version. Both contain the exact same medication — the price difference reflects different rebate and contract structures.
Ask your pharmacist or insurance company whether you can access the lower-priced version of Amjevita. In some cases, switching to the lower-WAC option can cut your out-of-pocket costs significantly, especially if you have a plan with coinsurance (where you pay a percentage of the drug cost).
If Amjevita is too expensive on your plan, a different Adalimumab biosimilar might be more affordable. Your insurance company's formulary determines which products have the lowest copay. Common alternatives include:
All of these are FDA-approved to treat the same conditions as Amjevita and work the same way. Switching to your plan's preferred product can sometimes save hundreds of dollars per month. For more details, read our guide to Amjevita alternatives.
Some states offer pharmaceutical assistance programs for residents who need help affording expensive medications. Eligibility varies by state and is usually based on income. Your state's health department website will have information about available programs.
Organizations like the Patient Access Network (PAN) Foundation, HealthWell Foundation, and NeedyMeds offer copay assistance grants for patients with specific diagnoses. These foundations may cover all or part of your Amjevita copay. Funding is limited and grant cycles open and close throughout the year, so check regularly.
Pharmaceutical representatives sometimes leave sample medications at doctor's offices. While samples aren't a long-term solution, they can cover a dose or two while you're waiting for financial assistance to kick in.
If your insurance denied coverage for Amjevita, don't accept the denial as final. Your doctor can submit an appeal with clinical documentation explaining why Amjevita is medically necessary. Many initial denials are overturned on appeal, especially when supported by clinical notes and treatment history.
No one should have to skip their biologic therapy because of cost. Amjevita is an important medication for managing serious autoimmune conditions, and there are real programs available to help you afford it. Start with the Amgen SupportPlus Co-Pay Program if you have private insurance, or the Safety Net Foundation if you're uninsured. Then explore discount cards and patient advocacy grants as additional options.
For help finding Amjevita at a pharmacy near you, use Medfinder. And for more information about Amjevita, check out our guides on what Amjevita is, side effects to watch for, and drug interactions to avoid.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
